395 related articles for article (PubMed ID: 30987191)
1. Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T; Mungenast F; Suváková M; Jäger W; Thalhammer T
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987191
[TBL] [Abstract][Full Text] [Related]
2.
Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of cannabinoids in CNS disease.
Croxford JL
CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
6. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights.
Bimonte S; Palma G; Cascella M; Cuomo A
Anticancer Res; 2023 Mar; 43(3):993-1000. PubMed ID: 36854495
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
Shah SA; Gupta AS; Kumar P
J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
[TBL] [Abstract][Full Text] [Related]
8. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
9. Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer.
ALSalamat HA; Abuarab SF; Salamah HM; Ishqair AH; Dwikat MF; Nourelden AZ; Qandil AN; Barakat Y; Barakat M
J Cannabis Res; 2024 May; 6(1):24. PubMed ID: 38755733
[TBL] [Abstract][Full Text] [Related]
10. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of cannabis in pain medicine.
Hosking RD; Zajicek JP
Br J Anaesth; 2008 Jul; 101(1):59-68. PubMed ID: 18515270
[TBL] [Abstract][Full Text] [Related]
12. [Progress in cannabis research from a pharmaceutical chemist's point of view].
Müller CE
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):818-824. PubMed ID: 31161229
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
[TBL] [Abstract][Full Text] [Related]
14. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
Caffarel MM; Sarrió D; Palacios J; Guzmán M; Sánchez C
Cancer Res; 2006 Jul; 66(13):6615-21. PubMed ID: 16818634
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype.
Almeida CF; Teixeira N; Correia-da-Silva G; Amaral C
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011388
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
Wilkinson JD; Williamson EM
J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
20. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.
Murase R; Kawamura R; Singer E; Pakdel A; Sarma P; Judkins J; Elwakeel E; Dayal S; Martinez-Martinez E; Amere M; Gujjar R; Mahadevan A; Desprez PY; McAllister SD
Br J Pharmacol; 2014 Oct; 171(19):4464-77. PubMed ID: 24910342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]